138 related articles for article (PubMed ID: 31354819)
1. Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy.
Takahashi H; Mori K; Sekino Y; Okumura T; Hiyama T; Fukuda K; Hasegawa N; Sakai M; Kikuchi S; Takei Y; Iizumi T; Sakurai H; Minami M
J Oncol; 2019; 2019():3580379. PubMed ID: 31354819
[TBL] [Abstract][Full Text] [Related]
2. Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CT.
Takahashi H; Sekino Y; Mori K; Okumura T; Nasu K; Fukuda K; Masuoka S; Iizumi T; Hasegawa N; Sakurai H; Minami M
Br J Radiol; 2020 Jan; 93(1105):20190375. PubMed ID: 31670572
[TBL] [Abstract][Full Text] [Related]
3. Three cases of hepatocellular carcinoma treated 4 times with proton beams.
Murakami M; Fukumitsu N; Okumura T; Numajiri H; Murofushi K; Ohnishi K; Mizumoto M; Ishikawa H; Tsuboi K; Sakurai H
Mol Clin Oncol; 2020 Jan; 12(1):31-35. PubMed ID: 31814974
[TBL] [Abstract][Full Text] [Related]
4. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?
Yoo GS; Yu JI; Park HC; Hyun D; Jeong WK; Lim HY; Choi MS; Ha SY
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847035
[TBL] [Abstract][Full Text] [Related]
5. Blood supply characteristics of pedunculated hepatocellular carcinoma prior to and following transcatheter arterial chemoembolization treatment: An angiographic demonstration.
Huang D; Chen Y; Zeng Q; Zhao J; Wu X; Wu R; Li Y
Oncol Lett; 2018 Mar; 15(3):3383-3389. PubMed ID: 29599845
[TBL] [Abstract][Full Text] [Related]
6. Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis.
Bush DA; Smith JC; Slater JD; Volk ML; Reeves ME; Cheng J; Grove R; de Vera ME
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):477-482. PubMed ID: 27084661
[TBL] [Abstract][Full Text] [Related]
7. Proton Beam Therapy for Hepatocellular Carcinoma: A Review of the University of Tsukuba Experience.
Mizumoto M; Oshiro Y; Okumura T; Fukumitsu N; Numajiri H; Ohnishi K; Aihara T; Ishikawa H; Tsuboi K; Sakurai H
Int J Part Ther; 2016 Mar; 2(4):570-578. PubMed ID: 31772968
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: a randomized phase III trial.
Okusaka T; Kasugai H; Shioyama Y; Tanaka K; Kudo M; Saisho H; Osaki Y; Sata M; Fujiyama S; Kumada T; Sato K; Yamamoto S; Hinotsu S; Sato T
J Hepatol; 2009 Dec; 51(6):1030-6. PubMed ID: 19864035
[TBL] [Abstract][Full Text] [Related]
9. Hepatic resection of hepatocellular carcinoma after proton beam therapy: A case report.
Kinjo N; Ikeda Y; Taguchi K; Sugimoto R; Maehara S; Tsujita E; Kawano H; Yamaguchi S; Egashira A; Minami K; Yamamoto M; Morita M; Toh Y; Okamura T
Hepatol Res; 2016 Mar; 46(5):483-8. PubMed ID: 26286377
[TBL] [Abstract][Full Text] [Related]
10. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
11. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
12. Postbiopsy arterioportal fistula in patients with hepatocellular carcinoma: clinical significance in transarterial chemoembolization.
Park HS; Lee SH; Kim YI; Lee JS; Lim MK; Park JW; Lee JH; Kim CM
AJR Am J Roentgenol; 2006 Feb; 186(2):556-61. PubMed ID: 16423968
[TBL] [Abstract][Full Text] [Related]
13. Proton beam therapy for large hepatocellular carcinoma.
Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
[TBL] [Abstract][Full Text] [Related]
14. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
Song Q; Ren W; Fan L; Zhao M; Mao L; Jiang S; Zhao C; Cui Y
Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
[TBL] [Abstract][Full Text] [Related]
17. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
[TBL] [Abstract][Full Text] [Related]
18. Proton beam therapy for hepatocellular carcinoma.
Yeung RH; Chapman TR; Bowen SR; Apisarnthanarax S
Expert Rev Anticancer Ther; 2017 Oct; 17(10):911-924. PubMed ID: 28825506
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
20. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
